181 related articles for article (PubMed ID: 20065024)
1. Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2.
Tong HH; Li YX; Stahl GL; Thurman JM
Infect Immun; 2010 Mar; 78(3):976-83. PubMed ID: 20065024
[TBL] [Abstract][Full Text] [Related]
2. Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.
Li Q; Li YX; Stahl GL; Thurman JM; He Y; Tong HH
Infect Immun; 2011 Jul; 79(7):2578-85. PubMed ID: 21502587
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
Tong HH; Lambert G; Li YX; Thurman JM; Stahl GL; Douthitt K; Clancy C; He Y; Bowman AS
PLoS One; 2014; 9(4):e95160. PubMed ID: 24740152
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans.
Held K; Thiel S; Loos M; Petry F
Mol Immunol; 2008 Sep; 45(15):3934-41. PubMed ID: 18672286
[TBL] [Abstract][Full Text] [Related]
5. Role of the alternative and classical complement activation pathway in complement mediated killing against Streptococcus pneumoniae colony opacity variants during acute pneumococcal otitis media in mice.
Li Q; Li YX; Douthitt K; Stahl GL; Thurman JM; Tong HH
Microbes Infect; 2012 Nov; 14(14):1308-18. PubMed ID: 22975410
[TBL] [Abstract][Full Text] [Related]
6. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.
Yuste J; Sen A; Truedsson L; Jönsson G; Tay LS; Hyams C; Baxendale HE; Goldblatt F; Botto M; Brown JS
Infect Immun; 2008 Aug; 76(8):3761-70. PubMed ID: 18541650
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation.
Mitchell DA; Taylor PR; Cook HT; Moss J; Bygrave AE; Walport MJ; Botto M
J Immunol; 1999 May; 162(10):5676-9. PubMed ID: 10229798
[TBL] [Abstract][Full Text] [Related]
8. Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media.
Han F; Yu H; Tian C; Li S; Jacobs MR; Benedict-Alderfer C; Zheng QY
Infect Immun; 2009 Jul; 77(7):3100-8. PubMed ID: 19414550
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.
Jönsson G; Lood C; Gullstrand B; Holmström E; Selander B; Braconier JH; Sturfelt G; Bengtsson AA; Truedsson L
Clin Immunol; 2012 Sep; 144(3):214-27. PubMed ID: 22842196
[TBL] [Abstract][Full Text] [Related]
10. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.
Yuste J; Botto M; Paton JC; Holden DW; Brown JS
J Immunol; 2005 Aug; 175(3):1813-9. PubMed ID: 16034123
[TBL] [Abstract][Full Text] [Related]
11. Glycolytic Metabolism Is Critical for the Innate Antibacterial Defense in Acute
Fan F; Ma Y; Ai R; Ding Z; Li D; Zhu Y; He Q; Zhang X; Dong Y; He Y
Front Immunol; 2021; 12():624775. PubMed ID: 33953708
[TBL] [Abstract][Full Text] [Related]
12. The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae.
Prince JE; Brayton CF; Fossett MC; Durand JA; Kaplan SL; Smith CW; Ballantyne CM
J Immunol; 2001 Jun; 166(12):7362-9. PubMed ID: 11390487
[TBL] [Abstract][Full Text] [Related]
13. Serum heat-labile opsonins in systemic lupus erythematosus.
Jasin HE; Orozco JH; Ziff M
J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
Cutler CW; Kalmar JR; Arnold RR
Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
[TBL] [Abstract][Full Text] [Related]
15. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
Xu Q; Pryharski K; Pichichero ME
Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628
[TBL] [Abstract][Full Text] [Related]
16. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.
Ren B; McCrory MA; Pass C; Bullard DC; Ballantyne CM; Xu Y; Briles DE; Szalai AJ
J Immunol; 2004 Dec; 173(12):7506-12. PubMed ID: 15585877
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
Ramos-Sevillano E; Urzainqui A; Campuzano S; Moscoso M; González-Camacho F; Domenech M; Rodríguez de Córdoba S; Sánchez-Madrid F; Brown JS; García E; Yuste J
Infect Immun; 2015 Feb; 83(2):591-603. PubMed ID: 25404032
[TBL] [Abstract][Full Text] [Related]
18. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.
Rupprecht TA; Angele B; Klein M; Heesemann J; Pfister HW; Botto M; Koedel U
J Immunol; 2007 Feb; 178(3):1861-9. PubMed ID: 17237437
[TBL] [Abstract][Full Text] [Related]
19. Innate Anti-microbial and Anti-chemotaxis Properties of Progranulin in an Acute Otitis Media Mouse Model.
Wang Z; He Q; Zhang X; Ma Y; Fan F; Dong Y; Xu W; Yin Y; He Y
Front Immunol; 2018; 9():2952. PubMed ID: 30619312
[TBL] [Abstract][Full Text] [Related]
20. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
Baker CJ; Edwards MS; Webb BJ; Kasper DL
J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
